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ive instropic respo 
art ~~~sp~a~tatj~~ has become an ~m~o~a~t t~ atm~~~ 
ity for patients with advan failure (9,1#). Be- 
uhrastruetural studies on e c tissue removed from 
em3 survivors of heart tnns ation have revealed no
evidence of reinnervation up ta 92 years after transplantation 
(Ol), the transplanted human heart offers the opportunity o
examine the effects of denervation. Electrophysiologic studies 
on human transplanted h arts have also revealed noevidence 
of reinnervation, such as in the failure of digoxin to prolong 
atrioventricular conduction a d the failure of atropine toin- 
crease heart ate (12,13). Although two recent studies (l&15) 
have tised the possibility that sympathetic e~~~e~t~ou cam 
~WIC after transplantation, another recent study (16), which 
used tissue norepinephrine as an index of reirmervation, con- 
cluded that he reinnervation rate is low in transplanted human 
ventricuiar myocardium. 
Investigations of beta-adrenergic eceptor mechanisms in 
surgically denervated animal hearts and transplanted human 
right ventricles have yielded conflicting results (17-23). 
073%1097193/$6.90 
rd, the denervated 
Blreuronal tissue synthesis of epinephrine (30) for heart rate 
and contractitity stimulation during exercise, and tra~~s~~amt 
the failure Of many transplant 
heart failure range (31). 
The purpose of the current investigation was to further 
characterize b ta-adrenergic re eptor signal transduction in 
denervated, transplanted human myocardium using g 
quantities ofright and left ventricular flee wall tissue t 
from explanted, previously transpla 
Left and right ventricular myocardium from previously 
transplanted hearts was abed from nine pali 
men, one wornan, with anage of49 t- 5 [S 
who were undergoing retrans,~~a~tat~o~ because of graft 
atherosclerosis 24.6 f 4 months (range 9 to 49) after the 
initial. orthotocrpic heart ransplantation. The age of the hearts 
removed from these nine patients was 29 * 3 years, Global 
systolic function was normal, as assessed by cardiac sathe- 
terization, echocardiography and radionuclide t chniques: 
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19, to S-point betaxolol-[‘251]iodocyanopindolol or 
CGP207k2A-[‘*51]iodocyanopindolo1 competition curves, as 
previously described (4,331. Beta,- and be&-receptor densities 
were obtained by multiplying their espective fI*dctions bythe 
tti be&mptor density, as measured by [ ‘zI)iodocyanopin- 
do@ ti curves, The [‘2SI~odocyanopindolol concen- 
tration u& in the competition curves was SO to 100 pmotiites, 
at least five times the dissociation constant. Adenylyl cyciase 
activity was measured in a gently washed particulate frrtction 
t ventricular free wall 
oomassie b~~e~~~in~d protein bands 
two-dimensional tr nsmission densit- 
bed (34). The levels of the 
proteins in ~e~~b~es 
hearts were then cdcu- 
EIS a percent of the mean value of the donor hearts. 
ultiple sampIes were used on e 
The nlethods of anal 
ventricles relative to the hiiher 
donor ventricles. Figure 2 shows tissue 
ersus duration of the transplant period for 
ventiks. No obvious relation is apparent (r = 0.04, 
~~~~~viou~~~ t~~s~~~~t~d hearts 1’7.9 * 4.4 pmollliter, 
donors 13.0. I 2.1 pmoyiiter (p = NS). 
The increase in~~~-~~e@tor density noted in both left 
1. Tissue norqkephrine (NE) levels in previously trans- 
planted (TX) and control vcrt~tricles fromorgan donors. LV = left 
ventricle; RV = right ventricle. 
Dolmor LV Donor RW 
T&k 2. Beta-Receptor Data in Left and Right Ventricles of 
Previously Transplanted and Organ Dolnor Hearts 
Bela-Receptor Density 
(fmallmg) tkrcent 
-____I 
Total Beta, Beta2 Beta, Beta2 
-- 
Left ventricles 
TX (n = 9) 91.7 65.8 26.2” 71.0t 29.3t 
I- 10.2 t8.4 22.1 11.1 11.2 
Donor (n = 26) 84.7 65.0 19.7 76.1 23.8 
25.1 24.4 k8.6 21.7 ! -1-1.8 
Right ventricles I 
TX (n = 9) 88.4 5s.9t 31.8 63.6” ’ 35.6’ 
214.0 29.4 t5.9 23.3 k3.0 
Donor (n = 26) 94.3$ 73.01 16.8 80.41 18.9P 
+5.9 A5.6 t2.0 +21.0 $?.2 
*p < 0.05 vs. donors. tp < 0.10 vs. donors. Sp < 0.10 vs. respective left 
ventricular subgroup. $p < 0.05 vs. respective left ventricular subgroup. 
Values presented are mean value k SEM. TX = transplanted. 
The increased beta,-receptor d~~s~~y in bet 
the tendency to a lower b~ta,~~,~cc~~o~ density in r&t 
ventricles and the altered beta,-lbeta,-recefutor . btype ratio 
were not r&ted to the age of the reci t (r < 0.30, p = 
for all variables or exphnkd hearts) Q the type of hem 
ive- 
me &se bed 
tively, &ha-Gi and alpha-G, are S~QWII in T&k 4. h 8 
subset of left ventricles from the re%ranspla~lt nd donor 
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3. Adenylyl Cyclase Data in Left and Right Ventricles ofPreviously Transplanted and Organ Donor Hearts ~rn~~rn~~ per mg 
syclic adenosine monophosphate) 
Adenylyl Cyclase Stimulation (stimulated minus basal ctivity) 
Basal -IsoProterenol VIP 
Activity ( W mobliter) !10V6 mobliter) 
11.0 39.8* 13.7 
22.2 23.3 -cl.5 
10.3 31.4 11.2 
sQ.7 f2.1 2146 
Sodium Fluoride 
110-* mofliter) 
45.7 
-r5,1 
41.6 
z2,86 
GPPNHP 
(WJ moVliter) 
16.8 
22.4 
13.5 
z-l.3 
a di~erence inthe radiolabcling of 
J), Shown in Table 5 are the 
isoproterenol and calcium in
en fkom the two groups. As 
exhibit no di@erence in tension 
renal or calcium. Additionally, 
the median effective dose for isoprotennol was not difkrcnt 
in the two groups. 
t retation tothe number 
t (5;). The results on total 
nt with previous data 
ium to be subjected to he 
tion for the f~~~wre to d~~o~st~tc 
beta- or betat-receptor population 
in the t~ns~lanted human heart is sympathetic reinnervation 
be tissue was not truly dene 
etic reinncw&ion fthe left or right ventricular free 
wall did not occur in the nine hearts examined. 
The new and surprising information forthcoming from 
this investigation s that beta2-receptors are increased in 
transplanted human ventricles, a finding not reported in
p=vious endomyocardial biopsy investigations, which mea- 
sured only total beta-receptor density compared with control 
ventricles (21,23) or measured betaJbeta,-receptor subtype 
proportions serially in the same subjects (24). The increase 
r density in the left and right ventricular free 
ement with nsults in rigkt ventricular endo- 
psy reported by von der Leyen et al. (M), 
who found an increase in beta,-receptor density over time in 
subjects who underwent trans 
not iscbemic ~d~~myo~athy. 
did not find such an increase in be&-receptor density in 
transplant subjects who had serial biopsies, the sample size 
was smaller. Both of these right ventricular endomyocardial 
investigations (2440) reported achange to a lower popula- 
ve of the nine patients with previous heart 
ession of beta,- versus beta,-re~e~to 
(42). Additionally, an effect of other medications, such as 
cyclosporine, in activating beta+332 expression cannot 
be excluded. Other psssibie me&an that could poten- 
tially account for up-regulation f beta,-receptors incIude 
bemody~amicts~ze changes, which occ in the ~ra~s~~ant~d 
heart (43), or the loss of innervation. hatever the cause, 
up-regulation f beta,?-receptors in the human heart is un- 
situation. 
tars. The increased bet ulation in previously 
transplanted ventricles appeared to be functional because 
isoprotereuol mediation ofadetrylyl cyclase stimulation was 
increased in both left and right ventricles. In nonfaili 
human ventricular myocardium, the majority (>75%) 
adenylyl cyclase stimulation is mediated by the minority, 
beta2-receptor p pukttion by virtue of their more eikient 
coupling to the enzyme (7,8,44). Thus, isoproterenol stimu- 
lation ofadenylyl cyclase is a.beta,-receptor-selective phar-
macologic probe, whereas stimulation ofmuscle contra*;tion 
reflects occupancy of both receptor subtypes in direct rela- 
tion to their relation to the numbers present (4). lIespit the 
fact that isoproterenol stimulation ofadunylyl cyclasr, was 
increased in both ventricles of previously tra 
hearts, responses to sodium fluoride (G protein medisted), 
GppNHp (G protein mediated) and forskolin (G protein 
sensitive, catalytic subunit rrydiated) were not altered. Re- 
sults with pert&s toxin- and cholera toxin-catalyzed a e- 
eta=receptor uneou- 
tricles does not d 
removed from co 
tions. The transplante 
developing exercise re 
denervation and is de 
receptors are thought to be the “epinephrine r ceptor” (48), 
the transplanted, denervated human heart has essentially 
undergone a beta-re 
with a higher epine 
transplanted human he 
sitivity (21,22) toepinep 
rflent is to increase t 
support the transplanted heart. 
summary. Previously transp~amted human ve 
myocardium exhibits no evidence of the expected result of 
surgical denervation, up-regulation f b~ta,-adr~~er~~~ re- 
ceptors and evidence of altered 
transduction. I stead, the trattspl 
an up-regulation f beta2-adrene 
a lower beta,lbeta2-receptor ra io. 
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